Feb 01, 2018 21:02 pm UTC| Business
VANCOUVER, British Columbia, Feb. 01, 2018 -- Intrinsyc Technologies Corporation (TSX:ITC) (OTC:ISYRF) (“Intrinsyc”), a leading provider of solutions for the development of embedded and IoT devices and Stream TV...
YRC Worldwide Reports Fourth Quarter and Full-Year Results for 2017
Feb 01, 2018 21:02 pm UTC| Business
Fourth quarter results include Operating Income of $11.3 million and Adjusted EBITDA of $58.5 million CDA notes maturity extended and outstanding principal reduced OVERLAND PARK, Kan., Feb. 01, 2018 -- YRC Worldwide...
HCi Viocare Comments on Recent Stock Volume and Price Increase
Feb 01, 2018 21:01 pm UTC| Business
GLASGOW, SCOTLAND , Feb. 01, 2018 -- HCi Viocare has been advised of a significant increase in the share price and trading volume of the Company's shares beginning Wednesday January 31, 2018. The Company has been...
Iridium Announces Release Date for Fourth-Quarter 2017 Financial Results
Feb 01, 2018 21:01 pm UTC| Business
MCLEAN, Va., Feb. 01, 2018 -- Iridium Communications Inc. (Nasdaq:IRDM) (“Iridium”) will host a conference call on Thursday, February 22, 2018 at 8:30 a.m. Eastern Time (ET) to discuss the Company’s fourth-quarter 2017...
Atossa Genetics Presents Additional Findings from its Phase 1 Study of Oral Endoxifen
Feb 01, 2018 21:01 pm UTC| Business
SEATTLE, Feb. 01, 2018 -- Atossa Genetics Inc. (NASDAQ:ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions, today announced...
Women In Bio Announces Jane Wasman Appointed Chair of Sellas Life Sciences’ Board of Directors
Feb 01, 2018 21:01 pm UTC| Business
NEW YORK, Feb. 01, 2018 -- Women In Bio (WIB), an organization of professionals committed to promoting careers, leadership, and entrepreneurship of women in the life sciences, announced today the appointment of another...
Feb 01, 2018 21:01 pm UTC| Business
NEWARK, Calif., Feb. 01, 2018 -- CymaBay Therapeutics, Inc. (Nasdaq:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today...
China Signals Subtle Treasury Pullback: Banks Urged to Ease US Debt Exposure
China Signals Quiet Treasury Trim: Banks Told to Ease Up on US Debt
The “Takaichi Trade”: How Japan’s First Female PM Is Shaping the Yen
How the US–India tariff truce boosts major Indian industries, Surat to Pharma